The quest to fully understand the human microbiome and its profound impact on health just got a significant boost. mbiomics GmbH, a company dedicated to decoding these biological secrets with a novel approach, has secured $35.3M in Series A funding.
This capital infusion, backed by investors MIG Fonds and Bayern Kapital, will fuel mbiomics' mission to improve people's lives. The company aims to translate its deeper understanding of the microbiome into insights that better inform targeted therapies and guide individuals toward a healthier life.















